• No results found

Novel genetic risk factors for venous thrombosis; a haplotype- based candidate gene approach Uitte de Willige, S.

N/A
N/A
Protected

Academic year: 2021

Share "Novel genetic risk factors for venous thrombosis; a haplotype- based candidate gene approach Uitte de Willige, S."

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Uitte de Willige, S. (2007, May 23). Novel genetic risk factors for venous

thrombosis; a haplotype-based candidate gene approach. Hemostasis and

Thrombosis Research Center, Department of Hematology, Faculty of Medicine,

Leiden University. Retrieved from https://hdl.handle.net/1887/11970

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis

in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/11970

Note: To cite this publication please use the final published version (if

applicable).

(2)

Novel genetic risk factors for venous thrombosis;

a haplotype-based candidate gene approach

(3)
(4)

Novel genetic risk factors for venous thrombosis;

a haplotype-based candidate gene approach

PROEFSCHRIFT

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van de Rector Magnificus prof. mr. P.F. van der Heijden, volgens besluit van het College voor Promoties

te verdedigen op 23 mei 2007 klokke 15:00 uur

door

Shirley Uitte de Willige geboren te Den Haag

in 1978

(5)

Promotores: Prof. dr. R.M. Bertina

Prof. dr. F.R. Rosendaal

Co-promotor: Dr. M.C.H. de Visser

Referent: Dr. R.A.S. Ariëns (University of Leeds)

Overige leden: Prof. dr. P.E. Slagboom Prof. dr. R.G. Westendorp Prof. dr. T.W. Huizinga

The research described in this thesis was financially supported by a grant of the Netherlands Organization for Scientific Research (NWO, grant 912-02-036) and was performed at the Hemostasis and Thrombosis Research Center, Department of Hematology, Leiden University Medical Center, the Netherlands.

Financial support by the Netherlands Heart Foundation and the J.E. Jurriaanse Stichting for the publication of this thesis is gratefully acknowledged.

Additional support was kindly provided by the Dr. Ir. Van de Laar Stichting and Eurogentec.

Coverdesign: Aat van Wijngaarden

© 2007 S. Uitte de Willige ISBN: 978-90-9021729-1

Printed by Printpartners Ipskamp, Enschede, the Netherlands

(6)

‘Het leven is wat je gebeurt terwijl je andere plannen maakt’

Acda & de Munnik (origineel van John Lennon)

Voor jou, pap

(7)
(8)

Table of Contents

page Chapter 1

General Introduction 11

Chapter 2

Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis

25

Chapter 3 Fibrinogen

3.1 Genetic variation in the fibrinogen gamma gene increases the risk of deep venous thrombosis by reducing plasma fibrinogen γ' levels

41

3.2 Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ'/γA mRNA ratio.

63

3.3 Polymorphisms in the 3’-end of the fibrinogen gamma gene and risk of venous thromboembolism in the African-American and Caucasian population

79

3.4 Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction

93 3.5 Fibrinogen gamma in ischemic stoke: a case-control study 101

Chapter 4

Selectin haplotypes and the risk of deep venous thrombosis;

Influence of linkage disequilibrium with the Factor V Leiden mutation

115

Chapter 5

General Discussion and Summary 133

Samenvatting 155 Publications and Abstracts 165

Nawoord 171

Curriculum Vitae 175

(9)

Referenties

GERELATEERDE DOCUMENTEN

In this study, we investigated the effect of haplotypes of SELE, SELL, SELP upstream and downstream of the recombination hotspot and SNPs of the P-selectin ligand PSGL-1 on DVT

Since elevated levels of total fibrinogen have also been associated with an increased risk of arterial thrombosis, we additionally studied the association of the four

Omdat verhoogde spiegels van totaal fibrinogeen zowel het risico op veneuze als op arteriële trombose verhogen, is ook gekeken of de haplotypen van FGG geassocieerd zijn met

Genetic variation in the fibrinogen gamma gene increases the risk of deep venous thrombosis by reducing plasma fibrinogen γ’ levels.. White SJ, Uitte de Willige S, Verbove D,

171 Het promotie onderzoek beschreven in dit proefschrift werd uitgevoerd op de afdeling Hemostase en Trombose Onderzoek van het Leids Universitair Medisch Centrum onder leiding

‘Novel genetic risk factors for venous thrombosis; a haplotype-based candidate gene approach’ in het Hemostasis and Thrombosis Research Center van het Leids Universitair

Bij het berekenen van het tromboserisico voor SNPs of haplotypen van de genen die coderen voor E-selectine, L-selectine of P-selectine moet gecorrigeerd worden voor

The research described in this thesis was fi nancially supported by the Netherlands Organization for Scientifi c Research (NWO, grant 912-02-036) and was performed at the